Business article - March 15, 2024
BICO founders leave after eight years
Following discussions with the board, the company’s founders Erik Gatenholm and Hector Martinez are leaving BICO. “I want to thank Erik and Hector for their efforts. Without them, the company would not have existed, let alone contributed to the change in the industry,” says Rolf Classon, Chairman of the Board. Erik Gatenholm and Hector Martinez […]
Biotech Business - March 15, 2024
NextCell Pharma establishes a subsidiary company
NextCell Pharma has formed a subsidiary company, QVance, specializing in quality control analytics. QVance, based in Huddinge, will specialize in quality analyses for advanced therapeutic companies, including NextCell, in the growing cell and gene therapy market. “It will address a large gap in the Nordic region, where there is a significant lack of local providers […]
Business article - March 12, 2024
Key take aways about the Joint Clinical Assessment process
On February 20th, SwedenBIO and Cencora PharmaLex organized a Brain & Breakfast event in Stockholm about the EU HTA process and challenges and opportunities for implementation in Sweden. During a 60 minute discussion, participants delved into the current landscape of the Joint Clinical Assessment (JCA), both from a European and Swedish perspective, offering insights from […]
Business article - February 29, 2024
Center for Translational Research launches CTC Netherlands
Center for Translational Research (CTR) expands its portfolio of life science service companies through the establishment of CTC Netherlands BV. CTC Netherlands BV is CTR group’s first company outside of Sweden. The new company will operate a clinical research unit that specializes in early phase patient research and healthy volunteer studies that require invasive procedures. […]
Biotech Business - February 28, 2024
NextCell Pharma updates growth strategy
The company’s strategic changes include a staff reduction, Cellaviva becoming a wholly owned subsidiary and the GMP facility will have new sources of revenue. NextCell develops the cell therapy drug ProTrans for the treatment of type 1 diabetes. ProTrans is now being evaluated in a clinical trial. In addition, a five year follow-up of previous […]
Business article - February 27, 2024
BMC in Uppsala is being modernized
The Biomedical Center (BMC) will have improved study spaces, greener courtyards, more energy measures, more welcoming entrances and a new clinical training centre. BMC, located in the southern parts of central Uppsala, was built in stages from the late 1960s until 1985. The building has since been fitted with several extensions and today consists of […]
